Better Buy: Vertex Pharmaceuticals vs. Galapagos
Two rising biotech stocks. One clear long-term winner.
Galapagos
GLPG
GLPG
$119.01
$0.95
0.8%
BATS BZX Real Time Price as of May 24, 2019, 11:12 a.m.
View Interactive GLPG Charts
GALAPAGOS NV SPON ADR REPR 1 ORD SHS
News & Analysis: Galapagos
All
Market Moves
Earnings
Galapagos NV (GLPG) Q1 2019 Earnings Call Transcript
GLPG earnings call for the period ending March 31, 2019.
Why Galapagos NV Stock Bolted Higher in March
Galapagos' experimental rheumatoid arthritis drug hit the mark in two late-stage studies last month.
Why BlackBerry, Galapagos, and Progress Software Jumped Today
Find out which of these stocks fared the best as the quarter came to a close.
Why Galapagos Stock Is Crushing It Today
The biotech reported nothing but good news from multiple clinical trials of its promising immunology drug.
3 Top Biotech Stocks to Buy in March
These three healthcare gems have the full attention of our team of experts.
2 Biotech Stocks With Major Incoming Catalysts
Clinical trial readouts expected before the end of March will put shares of these drugmakers on the move.
3 Biotech Stocks With Major Incoming Catalysts
These three biotechs will soon present clinical trial results that could send their share prices screaming in one direction or the other.
Better Buy: Vertex Pharmaceuticals Incorporated vs. Galapagos NV
Which stock wins in a battle between these two biotechs?
Is Galapagos NV a Buy Now?
It's beginning to look like AbbVie made a big mistake.
